149 related articles for article (PubMed ID: 15895163)
1. Targeting exosites on blood coagulation proteases.
Monteiro RQ
An Acad Bras Cienc; 2005 Jun; 77(2):275-80. PubMed ID: 15895163
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
Monteiro RQ; Zingali RB
Arch Biochem Biophys; 2000 Oct; 382(1):123-8. PubMed ID: 11051105
[TBL] [Abstract][Full Text] [Related]
3. Ixolaris: a factor Xa heparin-binding exosite inhibitor.
Monteiro RQ; Rezaie AR; Ribeiro JM; Francischetti IM
Biochem J; 2005 May; 387(Pt 3):871-7. PubMed ID: 15617517
[TBL] [Abstract][Full Text] [Related]
4. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
Monteiro RQ; Zingali RB
Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
[TBL] [Abstract][Full Text] [Related]
5. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.
Francischetti IM; Valenzuela JG; Andersen JF; Mather TN; Ribeiro JM
Blood; 2002 May; 99(10):3602-12. PubMed ID: 11986214
[TBL] [Abstract][Full Text] [Related]
6. Ixolaris binding to factor X reveals a precursor state of factor Xa heparin-binding exosite.
Monteiro RQ; Rezaie AR; Bae JS; Calvo E; Andersen JF; Francischetti IM
Protein Sci; 2008 Jan; 17(1):146-53. PubMed ID: 18042685
[TBL] [Abstract][Full Text] [Related]
7. Identification of the substrate-binding exosites of two snake venom serine proteinases: molecular basis for the partition of two essential functions of thrombin.
Maroun RC; Serrano SM
J Mol Recognit; 2004; 17(1):51-61. PubMed ID: 14872537
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic properties of Ixolaris, a potent inhibitor of the extrinsic pathway of the coagulation cascade.
Nazareth RA; Tomaz LS; Ortiz-Costa S; Atella GC; Ribeiro JM; Francischetti IM; Monteiro RQ
Thromb Haemost; 2006 Jul; 96(1):7-13. PubMed ID: 16807644
[TBL] [Abstract][Full Text] [Related]
9. Interaction of bothrojaracin with prothrombin.
Zingali RB; Bianconi ML; Monteiro RQ
Haemostasis; 2001; 31(3-6):273-8. PubMed ID: 11910195
[TBL] [Abstract][Full Text] [Related]
10. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
[TBL] [Abstract][Full Text] [Related]
11. NMR structure determination of Ixolaris and factor X(a) interaction reveals a noncanonical mechanism of Kunitz inhibition.
De Paula VS; Sgourakis NG; Francischetti IMB; Almeida FCL; Monteiro RQ; Valente AP
Blood; 2019 Aug; 134(8):699-708. PubMed ID: 31133602
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
[TBL] [Abstract][Full Text] [Related]
13.
De Paula VS; Silva FHS; Francischetti IMB; Monteiro RQ; Valente AP
Biomol NMR Assign; 2017 Oct; 11(2):293-296. PubMed ID: 28856584
[TBL] [Abstract][Full Text] [Related]
14. Functional characterisation of vizottin, the first factor Xa inhibitor purified from the leech Haementeria vizottoi.
Oliveira DG; Alvarez-Flores MP; Lopes AR; Chudzinski-Tavassi AM
Thromb Haemost; 2012 Sep; 108(3):570-8. PubMed ID: 22782262
[TBL] [Abstract][Full Text] [Related]
15. Exosites in the substrate specificity of blood coagulation reactions.
Bock PE; Panizzi P; Verhamme IM
J Thromb Haemost; 2007 Jul; 5 Suppl 1(Suppl 1):81-94. PubMed ID: 17635714
[TBL] [Abstract][Full Text] [Related]
16. Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II.
Monteiro RQ; Rapôso JG; Wisner A; Guimarães JA; Bon C; Zingali RB
Biochem Biophys Res Commun; 1999 Sep; 262(3):819-22. PubMed ID: 10471408
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulant activity of a sulfated galactan: serpin-independent effect and specific interaction with factor Xa.
Glauser BF; Rezende RM; Melo FR; Pereira MS; Francischetti IM; Monteiro RQ; Rezaie AR; Mourão PA
Thromb Haemost; 2009 Dec; 102(6):1183-93. PubMed ID: 19967150
[TBL] [Abstract][Full Text] [Related]
18. Amblyomin-X having a Kunitz-type homologous domain, is a noncompetitive inhibitor of FXa and induces anticoagulation in vitro and in vivo.
Branco VG; Iqbal A; Alvarez-Flores MP; Sciani JM; de Andrade SA; Iwai LK; Serrano SM; Chudzinski-Tavassi AM
Biochim Biophys Acta; 2016 Oct; 1864(10):1428-35. PubMed ID: 27479486
[TBL] [Abstract][Full Text] [Related]
19. Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: lessons from a tick salivary protein.
Schuijt TJ; Bakhtiari K; Daffre S; Deponte K; Wielders SJ; Marquart JA; Hovius JW; van der Poll T; Fikrig E; Bunce MW; Camire RM; Nicolaes GA; Meijers JC; van 't Veer C
Circulation; 2013 Jul; 128(3):254-66. PubMed ID: 23817575
[TBL] [Abstract][Full Text] [Related]
20. Moojenactivase, a novel pro-coagulant PIIId metalloprotease isolated from Bothrops moojeni snake venom, activates coagulation factors II and X and induces tissue factor up-regulation in leukocytes.
Sartim MA; Costa TR; Laure HJ; Espíndola MS; Frantz FG; Sorgi CA; Cintra AC; Arantes EC; Faccioli LH; Rosa JC; Sampaio SV
Arch Toxicol; 2016 May; 90(5):1261-78. PubMed ID: 26026608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
